TahmidRahmanMDFACC

Cardiology • Stony Brook, NY

Clinical Assistant Professor of Medicine

Join to view full profile

Dr. Rahman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Rahman's full profile

Already have an account?

Office
101 Nicolls Road
Health Sciences Center, T-16-080
Stony Brook, NY 11794
Phone+1 631-444-1066

Fax+1 631-444-1054

Summary

Clinical Assistant Professor of Medicine at Stony Brook Medicine, division of cardiology. I focus on preventative cardiology and quality and safety in cardiology. I am board certified in echocardiography, nuclear cardiology, and clinical lipidology.

Education & Training

Stony Brook Medicine/University HospitalFellowship, Cardiovascular Disease, 2019 - 2021
Drexel University College of Medicine/Hahnemann University HospitalFellowship, Cardiovascular Disease, 2018 - 2019
Drexel University College of Medicine/Hahnemann University HospitalChief Residency, Internal Medicine, 2017 - 2018
Drexel University College of Medicine/Hahnemann University HospitalResidency, Internal Medicine, 2014 - 2017
St. George's University School of MedicineClass of 2014

Certifications & Licensure

NY State Medical License 2020 - 2025
PA State Medical License 2014 - 2021
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Clinical Trials

Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease Start of enrollment: 2021 Nov 23
Active, not recruiting
Phase 3
A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) Start of enrollment: 2021 Jun 25
Completed
Phase 3
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic Plaque Progression in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events Start of enrollment: 2022 Jul 08
Recruiting
Phase 3
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial Start of enrollment: 2022 Dec 14
Active, not recruiting
Phase 3
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction) Start of enrollment: 2020 Dec 16
Completed
Phase 3
EVOLVE-MI: EVOLocumab Very Early After Myocardial Infarction Start of enrollment: 2022 Oct 26
Active, not recruiting
Phase 4
FREEDOM COVID-19 Anticoagulation Strategy Start of enrollment: 2020 Sep 08
Completed
Phase 4
Join now to see all

Publications & Presentations

PubMed

Primary Hypoalphalipoproteinemia With Significant Premature Atherosclerosis.
Sumer Moussa, Jordan Price, Jesse Frye, On Chen, Tahmid Rahman
JACC. Case Reports. 2024-12-04
1 citations
Utility of coronary revascularization in patients with ischemic left ventricular dysfunction.
Mohammed Al-Sadawi, Michael Tao, Simrat Dhaliwal, Archanna Radakrishnan, Yang Liu
Cardiovascular Revascularization Medicine. 2024-08-01
1 citations
Safety and utility of mechanical circulatory support in patients with acute myocardial infarction complicated by cardiogenic shock: A systematic review and meta-analysis.
Jesse Frye, Michael Tao, Shivani Gupta, Chad Gier, Ravi Masson
Cardiovascular Revascularization Medicine. 2024-06-21

Professional Memberships

American College of Cardiology - ACC
Member
American Heart Association - AHA
Member
National Lipid Association
Member
Bangladeshi Medical Association of North America
Member